Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
Cervical Adenocarcinoma Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma, Not Otherwise Specified Stage IB2 Cervical Cancer AJCC v6 and v7 Stage II Cervical Cancer AJCC v7 Stage II Vaginal Cancer AJCC v6 and v7 Stage IIA Cervical Cancer AJCC v7 Stage IIB Cervical Cancer AJCC v6 and v7 Stage III Vaginal Cancer AJCC v6 and v7 Stage IIIB Cervical Cancer AJCC v6 and v7 Stage IVA Cervical Cancer AJCC v6 and v7 Stage IVA Vaginal Cancer AJCC v6 and v7 Vaginal Adenocarcinoma Vaginal Adenosquamous Carcinoma Vaginal Squamous Cell Carcinoma, Not Otherwise Specified Carcinoma Carcinoma, Squamous Cell Adenocarcinoma Uterine Cervical Neoplasms Vaginal Neoplasms Carcinoma, Adenosquamous Cisplatin External Beam Radiation Therapy Intensity-Modulated Radiation Therapy Internal Radiation Therapy Laboratory Biomarker Analysis Radiation Therapy Triapine
Lead Scientists at UC Health
- Loren K. Mell (ucsd)
Professor In Residence, Radiation Medicine and Applied Science. Authored (or co-authored) 134 research publications. Research interests: Personalized Medicine · Clinical Trials · Risk Modeling · Immune System · Imaging · Immunotherapy.
- Krishnansu S. Tewari (uci)
Professor, Obstetrics and Gynecology. Authored (or co-authored) 184 research publications.
- accepting new patients
- Start Date
- National Cancer Institute (NCI)
- Phase 3
- Study Type
- Last Updated